Commercialisation: Funding Innovative Nanotech Companies – Venture Forum

1 JUNE 2011
9:00-12:30
Room Mozart

The Innovation Union identifies access to risk-financing as one of the key challenges facing European technology companies. The Venture Forum will feature prominent investors revealing how they evaluate nanotechnology-related investments and how investors can contribute value to partner firms. The discussion will be followed by investment pitches from some of Europe’s most exciting nanotechnology start-ups.

Chair

KOPONEN, Pekka
Founder and CEO
Spinverse Oy (FI)


09.00 – 10.30 Investor Introductions and Discussion

Panelists will introduce themselves and their investment outlooks, and will then discuss:

  • How investors perceive the nanotechnology opportunity space
  • What investors look for in a nanotechnology company – and what they avoid
  • The role of venture capital in relation to other funding sources
  • How best to pitch investors

Panelists:

TOOTH, Jenny
Managing Director, Angel Capital Innovation (UK)

LUNDSTRÖM, Patrik
European Nano Invest AB (SE)

FLACH, Michael
Nanostart (DE)

HACKMANN, Claus
BASF Venture Capital (DE)


11.00 – 12.30 Venture Pitches

MADIBERK, Taavi – Skeleton Technologies (EE)

EASTHAM, Derek - NFAB Ltd (UK)

PILVI, Tero – Picosun Oy (FI)

ZOFFMANN GLUD, Sys – Nanoference (DK) Scientific coordinator, iNANO

LISZIEWICZ, Zsolt – COO, Genetic Immunity (HU)

BORBEY, Janos – CEO, BBS Nanotechnology (HU)

BRANDT, Johan - Managing Director, Genano (FI)

back

Comments are closed.